IRF9/ISGF3 Recombinant Antibody, Cy7 Conjugated
Product Specifications
Background
Transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta) . Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2.
Synonyms
Irf9; ISGF3; ISGF3G; p48.
Gene ID
10379
Swiss Prot
Q00978
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Human
Target
IRF9/ISGF3
Clonality
Recombinant
Conjugation
Cy7
Source
KLH conjugated synthetic peptide derived from human Interferon regulatory factor 9
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
743nm/767nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
10379
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882559-500 1x 500 µL
Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (IGHM/2559R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882066-100 1x 100 µL
CD45 / LCA (B-Cell Marker) (rPTPRC/1460), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 